the exciting future of bispecific antibodies
Published 5 years ago • 680 plays • Length 2:56Download video MP4
Download video MP3
Similar videos
-
4:12
bispecific antibodies in italy: current status and future outlooks
-
1:03
using bispecific antibodies instead of chemotherapy to reach pre-transplant remission in b-all
-
6:15
how to manage and report aes associated with bispecific antibody treatment in myeloma
-
1:33
sequencing and the management of adverse events when administering bispecifics for myeloma
-
2:50
phase i study of abbv383, a novel bcmaxcd3 bispecific antibody, in r/r multiple myeloma
-
1:52
evaluating the efficacy of obinutuzumab, ibrutinib, and venetoclax in richter's transformation
-
1:34
the future role of ai models in hematology and the need for high-quality data sets
-
1:13
the future of the ebmt patient advocacy track
-
4:24
crystal violet - biofilm assay method
-
3:57
monoclonal antibodies | health | biology | fuseschool
-
4:47
efficacy of novel t-cell bispecific engaging antibody, cd20-tcb (rg6026), for r/r nhl
-
5:24
safety by treatment phase and age when treating flt3-itd-mutated aml with quizartinib and chemo
-
3:20
bispecific antibody
-
4:48
an insight into the management of cytopenias in mf
-
2:04
introducing a phase ib/ii trial to evaluate tasquinimod for the treatment of myelofibrosis
-
2:25
real-world study of tixagevimab/cilgavimab in pre-exposure prophylaxis for allosct recipients
-
1:03
msi-high as a biomarker for immunotherapy in perioperative settings
-
34:26
safety considerations for the development of antibody drug conjugates
-
1:40
tip cell selection in blood vessel formation